Depressive symptoms and associated factors among HIV positive patients attending public health facilities of Dessie town: A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
02
2021
accepted:
23
07
2021
entrez:
5
8
2021
pubmed:
6
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Depressive symptoms are the most common psychiatric complication of Human Immunodeficiency Virus (HIV) infection. They are associated with poor drug adherence, treatment failure, and increase the risk for suicide. There was limited evidence of depressive symptoms among HIV-positive patients in the study area. So, this study aimed to determine the prevalence of depressive symptoms and associated factors among HIV-positive patients attending public health facilities of Dessie town, North-central Ethiopia, 2019. A cross-sectional study was conducted on 380 HIV-positive patients attending ART clinics in Dessie town, North-central Ethiopia, 2019. Samples were selected using systematic random sampling and the data were collected by using structured, pretested, and interviewer-administered questionnaires. Patient Health Questionnaire (PHQ-9) at a cut-off point of 5 was used to assess depressive symptoms. The data were entered by Epi data version 3.1 and analyzed by SPSS version 25. A binary logistic regression model was used to identify factors associated with depressive symptoms. The Adjusted Odds Ratio (AOR) along with a 95% Confidence Interval (CI) was estimated to measure the association. The level of significance was declared at a p-value of less than 0.05. The prevalence of depressive symptoms among HIV positive patients was 15.5% (95% CI: (12.4%, 19.2%)). Age 40-49 years compared to 30-39 years (AOR = 2.96, 95% CI: (1.01, 8.68)), age ≥50 years compared to 30-39 years (AOR = 3.81, 95% CI: (1.05, 13.8)), having perceived stigma (AOR = 10.2, 95%CI: (4.26, 24.4)) taking medication other than Antiretroviral Therapy (ART) (AOR = 2.58, 95% CI: (1.25, 5.33)) and history of opportunistic infections (AOR = 5.17, 95% CI: (1.31, 20.4)) were factors associated with depressive symptoms. The prevalence of depressive symptoms was low compared to previous studies. Age, perceived stigma, taking medication other than ART, and history of opportunistic infections were factors associated with depressive symptoms. Health education and counseling programs should be strengthened and target older patients, patients who took medications other than ART, patients who experienced perceived stigma and patients with a history of history opportunistic infections.
Sections du résumé
BACKGROUND
Depressive symptoms are the most common psychiatric complication of Human Immunodeficiency Virus (HIV) infection. They are associated with poor drug adherence, treatment failure, and increase the risk for suicide. There was limited evidence of depressive symptoms among HIV-positive patients in the study area. So, this study aimed to determine the prevalence of depressive symptoms and associated factors among HIV-positive patients attending public health facilities of Dessie town, North-central Ethiopia, 2019.
METHOD
A cross-sectional study was conducted on 380 HIV-positive patients attending ART clinics in Dessie town, North-central Ethiopia, 2019. Samples were selected using systematic random sampling and the data were collected by using structured, pretested, and interviewer-administered questionnaires. Patient Health Questionnaire (PHQ-9) at a cut-off point of 5 was used to assess depressive symptoms. The data were entered by Epi data version 3.1 and analyzed by SPSS version 25. A binary logistic regression model was used to identify factors associated with depressive symptoms. The Adjusted Odds Ratio (AOR) along with a 95% Confidence Interval (CI) was estimated to measure the association. The level of significance was declared at a p-value of less than 0.05.
RESULT
The prevalence of depressive symptoms among HIV positive patients was 15.5% (95% CI: (12.4%, 19.2%)). Age 40-49 years compared to 30-39 years (AOR = 2.96, 95% CI: (1.01, 8.68)), age ≥50 years compared to 30-39 years (AOR = 3.81, 95% CI: (1.05, 13.8)), having perceived stigma (AOR = 10.2, 95%CI: (4.26, 24.4)) taking medication other than Antiretroviral Therapy (ART) (AOR = 2.58, 95% CI: (1.25, 5.33)) and history of opportunistic infections (AOR = 5.17, 95% CI: (1.31, 20.4)) were factors associated with depressive symptoms.
CONCLUSION
The prevalence of depressive symptoms was low compared to previous studies. Age, perceived stigma, taking medication other than ART, and history of opportunistic infections were factors associated with depressive symptoms. Health education and counseling programs should be strengthened and target older patients, patients who took medications other than ART, patients who experienced perceived stigma and patients with a history of history opportunistic infections.
Identifiants
pubmed: 34352017
doi: 10.1371/journal.pone.0255824
pii: PONE-D-21-03982
pmc: PMC8341501
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255824Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Family Med Prim Care. 2017 Jul-Sep;6(3):549-553
pubmed: 29417006
PLoS One. 2012;7(7):e41699
pubmed: 22860006
HIV AIDS (Auckl). 2011;3:45-51
pubmed: 22096406
PLoS One. 2010 Dec 08;5(12):e14252
pubmed: 21170384
HIV Med. 2008 Jan;9(1):14-8
pubmed: 18199168
BMC Psychiatry. 2016 Nov 2;16(1):368
pubmed: 27806711
AIDS Behav. 2020 Jun;24(6):1752-1764
pubmed: 31720956
Infect Dis Clin North Am. 2007 Mar;21(1):181-200, x
pubmed: 17502235
Neuropsychiatr Dis Treat. 2017 Aug 08;13:2125-2131
pubmed: 28860769
Ann Gen Psychiatry. 2018 Oct 30;17:45
pubmed: 30386408
HIV Med. 2010 Jan;11(1):46-53
pubmed: 19601996
Nature. 2014 Nov 13;515(7526):181
pubmed: 25391942
J Virus Erad. 2018 Nov 15;4(Suppl 2):1-4
pubmed: 30515307
Am J Public Health. 2004 Jul;94(7):1133-40
pubmed: 15226133
Am J Psychiatry. 2001 May;158(5):725-30
pubmed: 11329393
AIDS. 2019 Dec 15;33 Suppl 3:S203-S211
pubmed: 31343430
BMC Res Notes. 2019 Aug 20;12(1):527
pubmed: 31429805
Neurol Ther. 2017 Jun;6(1):103-114
pubmed: 28316064
AIDS Res Ther. 2017 Mar 21;14:16
pubmed: 28331527
J Int Assoc Provid AIDS Care. 2015 Mar-Apr;14(2):136-40
pubmed: 23873218
BMC Int Health Hum Rights. 2015 Dec 28;15:33
pubmed: 26711659
J Int AIDS Soc. 2016 Jul 15;19(1):21133
pubmed: 27424601
Pan Afr Med J. 2017 Jan 30;26:43
pubmed: 28451021
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
AIDS Res Treat. 2019 Jan 2;2019:4610458
pubmed: 30719348
Trop Med Int Health. 2012 Jan;17(1):71-81
pubmed: 21967241
Depress Res Treat. 2019 Feb 3;2019:3250431
pubmed: 30863637
Curr HIV/AIDS Rep. 2008 Nov;5(4):163-71
pubmed: 18838056
AIDS Behav. 2011 Nov;15(8):1803-18
pubmed: 21484283
Curr Psychiatry Rep. 2015 Jan;17(1):530
pubmed: 25413636
HIV AIDS (Auckl). 2016 Nov 23;8:183-193
pubmed: 27920581